5//SEC Filing
HEILBRUNN KENNETH R 5
Accession 0001209191-05-007917
CIK 0000920465other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:32 PM ET
Size
13.5 KB
Accession
0001209191-05-007917
Insider Transaction Report
Form 5
HEILBRUNN KENNETH R
VP of Clinical Development
Transactions
- Other
Common Stock
2004-12-31$1.42/sh+554$786→ 11,028 total - Other
Common Stock
2004-06-30$1.48/sh+536$793→ 10,021 total - Other
Common Stock
2004-09-30$1.48/sh+453$670→ 10,474 total
Holdings
- 11,028
Common Stock
- 315,000
Stock Option (right to buy)
→ Common Stock (315,000 underlying)
Footnotes (2)
- [F1]Acquired pursuant to the Company?s Employee Stock Purchase Plan.
- [F2]Reporting only direct holdings, no transaction data is necessary
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001237530
Filing Metadata
- Form type
- 5
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 4:32 PM ET
- Size
- 13.5 KB